Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Combinations of Cannabinoids and Caffeine
NCT05478863Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol, caffeine and cannabidiol (4 arms), sponsored by Johns Hopkins University. Primary endpoints: Change in Driving Performance on the DRiving Under the Influence of Drugs (DRUID) and Driving Performance on the Driving Simulator. Started Jan 2023; status: completed.
02
Drugs
dronabinolcaffeinecannabidiol
Beyond the preview
Go deeper on NCT05478863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05478863.